{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T15:35:22Z","timestamp":1750779322383},"reference-count":165,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gofs.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,11,11]],"date-time":"2018-11-11T22:09:54Z","timestamp":1541974194000},"page":"806-822","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Contraception intra-ut\u00e9rine. RPC Contraception CNGOF"],"prefix":"10.1016","volume":"46","author":[{"given":"F.","family":"Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Paret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Linet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tanguy le Gac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Guerby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.10.004_bib0830","author":"United Nations, Department of Economic and Social Affairs, Population Division (2015)","year":"2015","journal-title":"Trends in Contraceptive Use Worldwide"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib0835","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.contraception.2013.10.003","article-title":"IUD use in France: women's and physician's perspectives","volume":"89","author":"Moreau","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.004_bib0840","series-title":"Medical eligibility criteria for contraceptive use","year":"2015"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib0845","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/jwh.2015.5190","article-title":"Positive testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the risk of pelvic inflammatory disease in IUD users","volume":"24","author":"Birgisson","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.12.024","article-title":"Long-acting reversible contraception in adolescents: a systematic review and meta-analysis","volume":"216","author":"Diedrich","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib0855","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/AOG.0000000000001036","article-title":"Young age, nulliparity, and continuation of long-acting reversible contraceptive methods","volume":"126","author":"Abraham","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib0860","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0000000000000144","article-title":"Effects of age, parity, and device type on complications and discontinuation of intrauterine devices","volume":"123","author":"Aoun","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib0865","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/AOG.0b013e31828b63a0","article-title":"Complications and continuation of intrauterine device use among commercially insured teenagers","volume":"121","author":"Berenson","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib0870","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0000000000000475","article-title":"Association of age and parity with intrauterine device expulsion","volume":"124","author":"Madden","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib0875","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.contraception.2007.12.011","article-title":"Copper-containing, framed intrauterine devices for contraception: a systematic review of randomized controlled trials","volume":"77","author":"O\u2019Brien","year":"2008","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.04.021","article-title":"Factors influencing repeated teenage pregnancy: a review and meta-analysis","volume":"217","author":"Maravilla","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib0890","article-title":"Practice Bulletin No.\u00a0186: long-acting reversible contraception: implants and intrauterine devices","volume":"130","author":"Committee on Practice Bulletins-Gynecology L-ARCWG","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.004_bib0895","series-title":"Medical eligibility criteria for contraceptive use: a WHO family planning cornerstone","year":"2010"},{"key":"10.1016\/j.gofs.2018.10.004_bib0900","author":"Faculty of Sexual and Reproductive Healthcare, Intrauterine Contraception, FSRH Clinical Guidance","year":"2015","journal-title":"Intrauterine Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib0905","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jogc.2015.12.002","article-title":"Canadian Contraception Consensus (Part 3\u00a0of 4): Chapter 7\u00a0\u2013\u00a0Intrauterine Contraception","volume":"38","author":"Black","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib0910","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bpobgyn.2014.05.006","article-title":"The contraception needs of the perimenopausal woman","volume":"28","author":"Hardman","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6\u00a0Suppl","key":"10.1016\/j.gofs.2018.10.004_bib0915","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.contraception.2007.01.010","article-title":"The levonorgestrel intrauterine system for use in peri- and postmenopausal women","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib0920","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0010-7824(95)00120-Y","article-title":"IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies","volume":"52","author":"Xiong","year":"1995","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib0925","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0015-0282(16)56455-3","article-title":"Health during prolonged use of levonorgestrel 20\u00a0micrograms\/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR)","volume":"61","author":"Sivin","year":"1994","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib0930","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00001648-199305000-00009","article-title":"Current use of an intrauterine device and risk of tubal pregnancy","volume":"4","author":"Rossing","year":"1993","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib0935","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"Suppl 3","key":"10.1016\/j.gofs.2018.10.004_bib0940","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/1471-0528.14011","article-title":"Risk factors for recurrent ectopic pregnancy: a case-control study","volume":"123","author":"Zhang","year":"2016","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib0945","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.contraception.2011.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review","volume":"86","author":"Ramhendar","year":"2012","journal-title":"Contraception"},{"issue":"9111","key":"10.1016\/j.gofs.2018.10.004_bib0950","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(97)10319-1","article-title":"Complications of use of intrauterine devices among HIV-1-infected women","volume":"351","author":"Sinei","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.09.002","article-title":"The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study","volume":"204","author":"Heikinheimo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.03.031","article-title":"A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus","volume":"197","author":"Stringer","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib0965","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.contraception.2006.09.006","article-title":"Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women","volume":"75","author":"Lehtovirta","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib0970","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/AOG.0000000000001087","article-title":"Intrauterine contraception among women living with human immunodeficiency virus: a randomized controlled trial","volume":"126","author":"Kakaire","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib0975","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.contraception.2008.05.006","article-title":"Safety of intrauterine contraceptive device (copper T 200\u00a0B) in women with cardiac disease","volume":"78","author":"Suri","year":"2008","journal-title":"Contraception"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.004_bib0980","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/hrt.2006.095240","article-title":"Risks of contraception and pregnancy in heart disease","volume":"92","author":"Thorne","year":"2006","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib0990","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11897-018-0392-x","article-title":"Contraceptive strategies in women with heart failure or with cardiac transplantation","volume":"15","author":"Maroo","year":"2018","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib0995","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.contraception.2012.08.010","article-title":"Physical examination prior to initiating hormonal contraception: a systematic review","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1000","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.contraception.2012.08.025","article-title":"Blood pressure measurement prior to initiating hormonal contraception: a systematic review","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1005","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","article-title":"Intrauterine device use and cervical cancer risk:a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.004_bib1010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","article-title":"Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26\u00a0epidemiological studies","volume":"12","author":"Castellsague","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.11.1053","article-title":"The effect of intrauterine devices on acquisition and clearance of human papillomavirus","volume":"216","author":"Averbach","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2015.06.012","article-title":"Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion","volume":"92","author":"Grentzer","year":"2015","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1025","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","article-title":"Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease","volume":"120","author":"Sufrin","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0956462413476269","article-title":"The 2012\u00a0International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe","volume":"24","author":"Brooks","year":"2013","journal-title":"Int J STD AIDS"},{"issue":"RR\u201303","key":"10.1016\/j.gofs.2018.10.004_bib1035","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6504a1","article-title":"U.S. Selected practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1701-2163(15)30636-8","article-title":"Best practices to minimize risk of infection with intrauterine device insertion","volume":"36","author":"Caddy","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.contraception.2012.08.015","article-title":"When can a woman have an intrauterine device inserted? A systematic review","volume":"87","author":"Whiteman","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1055","first-page":"220","article-title":"Intrauterine device termination rates and the menstrual cycle day of insertion","volume":"55","author":"White","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.004_bib1060","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/humrep\/det330","article-title":"Copper T380\u00a0intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle","volume":"28","author":"Turok","year":"2013","journal-title":"Hum Reprod"},{"issue":"9108","key":"10.1016\/j.gofs.2018.10.004_bib1065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(97)09086-7","article-title":"Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group","volume":"351","author":"Walsh","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1471-0528.1990.tb01828.x","article-title":"Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion","volume":"97","author":"Sinei","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1075","first-page":"CD001327","article-title":"Antibiotic prophylaxis for intrauterine contraceptive device insertion","author":"Grimes","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1783\/147118903101196846","article-title":"Intrauterine techniques: contentious or consensus opinion?","volume":"29","author":"Tolcher","year":"2003","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0255-0857.93040","article-title":"Prevention of healthcare-associated infections in general practice: current practice and drivers for change in a French study","volume":"30","author":"Gignon","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.gofs.2018.10.004_bib1090","author":"Soci\u00e9t\u00e9 de formation th\u00e9rapeutique du g\u00e9n\u00e9raliste -Haute Autorit\u00e9 de sant\u00e9, Service des Recommandations Professionnelles","year":"2007","journal-title":"Hygi\u00e8ne et pr\u00e9vention du risque infectieux en cabinet m\u00e9dical ou param\u00e9dical"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/13625187.2015.1031885","article-title":"Patients\u2019 experiences and providers\u2019 observations on pain during intrauterine device insertion","volume":"20","author":"Akintomide","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/AOG.0000000000002242","article-title":"Reducing pain during intrauterine device insertion: a randomized controlled trial in adolescents and young women","volume":"130","author":"Akers","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.contraception.2012.06.015","article-title":"Failed IUD insertions in community practice: an under-recognized problem?","volume":"87","author":"Dermish","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/ajo.12007","article-title":"Ease of intrauterine contraceptive device insertion in family planning settings","volume":"52","author":"Harvey","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0010-7824(02)00417-1","article-title":"Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?","volume":"67","author":"Harrison-Woolrych","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.004_bib1120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40834-016-0009-2","article-title":"Medical student simulation training in intrauterine contraception insertion and removal: an intervention to improve comfort, skill, and attitudes","volume":"1","author":"Bartz","year":"2016","journal-title":"Contracept Reprod Med"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.553","article-title":"Randomized trial of high- and low-fidelity simulation to teach intrauterine contraception placement","volume":"218","author":"Nippita","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1130","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ajog.2006.08.022","article-title":"Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen","volume":"195","author":"Hubacher","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"2\u00a0Pt 1","key":"10.1016\/j.gofs.2018.10.004_bib1135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/AOG.0000000000000362","article-title":"Predicting painful or difficult intrauterine device insertion in nulligravid women","volume":"124","author":"Kaislasuo","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.004_bib1140","article-title":"Interventions for pain with intrauterine device insertion","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/13625187.2014.903238","article-title":"Analgesic options for placement of an intrauterine contraceptive: a meta-analysis","volume":"19","author":"Pergialiotis","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13625187.2018.1469124","article-title":"Uterine or paracervical lidocaine application for pain control during intrauterine contraceptive device insertion: a meta-analysis of randomised controlled trials","volume":"23","author":"Perez-Lopez","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/13625187.2018.1428297","article-title":"Benefits of vaginal misoprostol prior to IUD insertion in women with previous caesarean delivery: a randomised controlled trial","volume":"23","author":"Maged","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.contraception.2017.01.003","article-title":"Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial","volume":"95","author":"Abdellah","year":"2017","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.004_bib1165","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/humrep\/dev137","article-title":"Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT","volume":"30","author":"Bahamondes","year":"2015","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jfprhc-2012-100422","article-title":"Does a full bladder assist insertion of intrauterine contraception? A randomised trial","volume":"39","author":"Cameron","year":"2013","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jfprhc-2016-101446","article-title":"A randomised trial comparing pain and ease of use of two different stabilising forceps for insertion of intrauterine contraception","volume":"42","author":"Speedie","year":"2016","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0010-7824(95)00253-7","article-title":"Evidence against tailstrings increasing the rate of pelvic inflammatory disease among IUD users","volume":"53","author":"Ebi","year":"1996","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijgo.2014.09.020","article-title":"A comparison of male partners\u2019 reactions to different intrauterine device strings","volume":"128","author":"Wiebe","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.contraception.2012.09.018","article-title":"The effect of follow-up visits or contacts after contraceptive initiation on method continuation and correct use","volume":"87","author":"Steenland","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0010-7824(03)00111-2","article-title":"Follow-up visits after IUD-insertion: sense or nonsense? A technology assessment study to analyze the effectiveness of follow-up visits after IUD insertion","volume":"68","author":"Neuteboom","year":"2003","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.004_bib1200","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1093\/humrep\/deg433","article-title":"The value of transvaginal ultrasound to monitor the position of an intrauterine device after insertion. A technology assessment study","volume":"18","author":"de Kroon","year":"2003","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.004_bib1205","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.7863\/jum.2007.26.10.1389","article-title":"Imaging of intrauterine contraceptive devices","volume":"26","author":"Peri","year":"2007","journal-title":"J Ultrasound Med"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/jfprhc-2013-100684","article-title":"Low-lying or malpositioned intrauterine devices and systems","volume":"40","author":"Golightly","year":"2014","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1215","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/uog.6421","article-title":"Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding","volume":"34","author":"Benacerraf","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(97)00072-3","article-title":"No relationship between the IUD position evaluated by ultrasound and complaints of bleeding and pain","volume":"56","author":"Faundes","year":"1997","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2004.12.026","article-title":"TCu 380A IUD: a reversible permanent contraceptive method in women over 35\u00a0years of age","volume":"72","author":"Bahamondes","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1230","first-page":"341","article-title":"Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C","volume":"56","year":"1997","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2014.02.011","article-title":"Extended use of the intrauterine device: a literature review and recommendations for clinical practice","volume":"89","author":"Wu","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.004_bib1240","author":"Haute Autorit\u00e9 de Sant\u00e9, Service des Recommandations Professionnelles","year":"2017","journal-title":"Fiches m\u00e9mo \u00ab\u00a0Conduite pratique de la contraception chez l\u2019homme et chez la femme\u00a0\u00bb"},{"key":"10.1016\/j.gofs.2018.10.004_bib1245","author":"Faculty of Sexual and Reproductive Healthcare, Contraception for women aged over 40 years, FSRH Clinical Guidance","year":"2017","journal-title":"Contraception for women aged over 40\u00a0years"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2016.02.024","article-title":"Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A","volume":"93","author":"Rowe","year":"2016","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.01.036","article-title":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2\u00a0years beyond Food and Drug Administration-approved duration","volume":"216","author":"McNicholas","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1260","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/01.AOG.0000435452.86108.59","article-title":"Characteristics associated with discontinuation of long-acting reversible contraception within the first 6\u00a0months of use","volume":"122","author":"Grunloh","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1270","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.contraception.2012.04.001","article-title":"Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis","volume":"86","author":"Kelekci","year":"2012","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1275","first-page":"CD005072","article-title":"Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery","author":"Abou-Setta","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.10.798","article-title":"Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis","volume":"198","author":"Cho","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0010-7824(95)00163-5","article-title":"The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status","volume":"52","author":"Milsom","year":"1995","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0010-7824(93)90136-U","article-title":"The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD","volume":"48","author":"Larsson","year":"1993","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1295","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.contraception.2008.11.012","article-title":"Side effects from the copper IUD: do they decrease over time?","volume":"79","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1300","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","article-title":"Unscheduled vaginal bleeding with progestin-only contraceptive use","volume":"216","author":"Zigler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1305","first-page":"CD006034","article-title":"Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use","author":"Grimes","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1310","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1315","first-page":"CD002126","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.contraception.2016.11.005","article-title":"A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg), in an Asia-Pacific population","volume":"95","author":"Fan","year":"2017","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1325","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/humrep\/deu063","article-title":"Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study","volume":"29","author":"Heikinheimo","year":"2014","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1330","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/AOG.0b013e31828c65d8","article-title":"Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial","volume":"121","author":"Sordal","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.09.021","article-title":"Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial","volume":"206","author":"Madden","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1340","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/humupd\/dmn003","article-title":"Intrauterine devices and intrauterine systems","volume":"14","author":"Eshre Capri Workshop Group","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.004_bib1345","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40264-018-0683-x","article-title":"Cohort study of psychiatric adverse events following exposure to levonorgestrel-containing intrauterine devices in UK general practice","volume":"41","author":"Slattery","year":"2018","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1350","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2018.01.010","article-title":"The relationship between progestin hormonal contraception and depression: a systematic review","volume":"97","author":"Worly","year":"2018","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1355","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.contraception.2015.01.021","article-title":"Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system","volume":"91","author":"Nahum","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1360","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1743-6109.2011.02266.x","article-title":"Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices","volume":"9","author":"Enzlin","year":"2012","journal-title":"J Sex Med"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1365","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2011.01.020","article-title":"Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center","volume":"84","author":"Bastianelli","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1370","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/ejc.8.3.129.134","article-title":"A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices","volume":"8","author":"Martin-Loeches","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1375","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2012.01.017","article-title":"Body weight and composition in users of levonorgestrel-releasing intrauterine system","volume":"86","author":"Dal\u2019Ava","year":"2012","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1380","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.04.002","article-title":"Fertility after discontinuation of contraception: a comprehensive review of the literature","volume":"84","author":"Mansour","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1385","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/13625187.2015.1010639","article-title":"Fertility after intrauterine device removal: a pilot study","volume":"20","author":"Stoddard","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1390","first-page":"304","article-title":"Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception","volume":"108","author":"Doll","year":"2001","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.004_bib1395","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJMoa010438","article-title":"Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women","volume":"345","author":"Hubacher","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1400","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajog.2003.07.021","article-title":"Pregnancy during the use of levonorgestrel intrauterine system","volume":"190","author":"Backman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1405","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1410","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.contraception.2011.06.010","article-title":"Pregnancy outcomes with an IUD in situ: a systematic review","volume":"85","author":"Brahmi","year":"2012","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1415","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/uog.1036","article-title":"Lost intrauterine devices during pregnancy: maternal and fetal outcome after ultrasound-guided extraction. An analysis of 82\u00a0cases","volume":"23","author":"Schiesser","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1420","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/00016348409155498","article-title":"A longitudinal study of Actinomyces israelii in the female genital tract","volume":"63","author":"Persson","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1425","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0010-7824(00)00121-9","article-title":"The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices","volume":"61","author":"Merki-Feld","year":"2000","journal-title":"Contraception"},{"issue":"6\u00a0Suppl","key":"10.1016\/j.gofs.2018.10.004_bib1430","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.contraception.2007.01.006","article-title":"IUDs and colonization or infection with Actinomyces","volume":"75","author":"Westhoff","year":"2007","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1435","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.contraception.2005.09.005","article-title":"Actinomyces in cervical smears of women using the intrauterine device in Singapore","volume":"73","author":"Kalaichelvan","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1440","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.contraception.2007.11.007","article-title":"Comparison of two procedures for routine IUD exchange in women with positive Pap smears for actinomyces-like organisms","volume":"77","author":"Merki-Feld","year":"2008","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1445","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/AOG.0b013e31828ac03a","article-title":"Pitfalls of research linking the intrauterine device to pelvic inflammatory disease","volume":"121","author":"Hubacher","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"8796","key":"10.1016\/j.gofs.2018.10.004_bib1450","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1455","first-page":"1","article-title":"Type of intrauterine device and the risk of pelvic inflammatory disease","volume":"62","author":"Lee","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1460","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.contraception.2016.02.004","article-title":"A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents","volume":"93","author":"Gemzell-Danielsson","year":"2016","journal-title":"Contraception"},{"issue":"7\u20138","key":"10.1016\/j.gofs.2018.10.004_bib1465","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gyobfe.2013.01.001","article-title":"Pelvic inflammatory disease and intrauterine contraceptive device. Monocentric continuous study of 70\u00a0cases over 5\u00a0years","volume":"41","author":"Maget","year":"2013","journal-title":"Gynecol Obstet Fertil"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1470","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/00016340902893678","article-title":"Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess","volume":"88","author":"Charonis","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1475","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.contraception.2012.08.011","article-title":"Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1480","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0301-2115(02)00342-1","article-title":"A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease","volume":"107","author":"Altunyurt","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1485","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0010-7824(81)90086-X","article-title":"Influence of an intrauterine device on the course of an acute salpingitis","volume":"24","author":"Soderberg","year":"1981","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1490","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/07853898909149184","article-title":"Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease","volume":"21","author":"Teisala","year":"1989","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1495","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(77)90012-9","article-title":"Investigation of a copper-intrauterine device (Cu-IUD) for possible effect on frequency and healing of pelvic inflammatory disease","volume":"15","author":"Larsson","year":"1977","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1500","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/13693786.2010.497972","article-title":"Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species","volume":"49","author":"Guzel","year":"2011","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1505","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/13693780902856626","article-title":"Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis","volume":"48","author":"Auler","year":"2010","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1510","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/01443615.2014.986442","article-title":"Does removal of CU-IUD in patients with biofilm forming candida really maintain regression of clinical symptoms?","volume":"35","author":"Cakiroglu","year":"2015","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1515","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.contraception.2007.09.009","article-title":"Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS)","volume":"77","author":"Lessard","year":"2008","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1520","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00404-016-4172-0","article-title":"The effect of contraceptive methods on reproductive tract infections risk: a cross-sectional study having a sample of 52,481\u00a0women","volume":"294","author":"Wang","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1525","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/OLQ.0b013e31823e68fe","article-title":"Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study","volume":"39","author":"Madden","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1530","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.contraception.2016.11.006","article-title":"Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome","volume":"95","author":"Brooks","year":"2017","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1535","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00404-013-2836-6","article-title":"Genitourinary infection prevalence among women who used an intrauterine device or oral contraceptives","volume":"288","author":"Demirbag","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1540","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.contraception.2015.01.007","article-title":"Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.004_bib1545","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/humrep\/des246","article-title":"Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study","volume":"27","author":"Kaislasuo","year":"2012","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1550","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(98)00029-8","article-title":"Perforations with intrauterine devices. Report from a Swedish survey","volume":"57","author":"Andersson","year":"1998","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1555","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/humrep\/det074","article-title":"Uterine perforation caused by intrauterine devices: clinical course and treatment","volume":"28","author":"Kaislasuo","year":"2013","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1560","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijgo.2014.02.017","article-title":"Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system","volume":"126","author":"Youm","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.004_bib1565","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/1471-0528.12619","article-title":"Dimensions of the endometrial cavity and intrauterine device expulsion or removal for displacement: a nested case-control study","volume":"121","author":"Liang","year":"2014","journal-title":"BJOG"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.004_bib1570","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/humrep\/del208","article-title":"Risk factors for IUD failure: results of a large multicentre case-control study","volume":"21","author":"Thonneau","year":"2006","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1575","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2011.12.002","article-title":"Does using tampons or menstrual cups increase early IUD expulsion rates?","volume":"86","author":"Wiebe","year":"2012","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1580","doi-asserted-by":"crossref","first-page":"183","DOI":"10.14366\/usg.15010","article-title":"Ultrasonography of intrauterine devices","volume":"34","author":"Nowitzki","year":"2015","journal-title":"Ultrasonography"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0015-0282(97)81476-8","article-title":"Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles","volume":"68","author":"Pakarinen","year":"1997","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1590","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/AOG.0b013e3182316308","article-title":"Malpositioned intrauterine contraceptive devices: risk factors, outcomes, and future pregnancies","volume":"118","author":"Braaten","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1595","first-page":"112","article-title":"Intrauterine device failure: relation to its location within the uterine cavity","volume":"81","author":"Anteby","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.12.058","article-title":"Intrauterine devices in early pregnancy: findings on ultrasound and clinical outcomes","volume":"204","author":"Moschos","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1605","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(00)00167-0","article-title":"T-shaped IUDs accommodate in their position during the first 3\u00a0months after insertion","volume":"62","author":"Faundes","year":"2000","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.004_bib1610","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2005.06.064","article-title":"Spontaneous upward movement of lowly placed T-shaped IUDs","volume":"72","author":"Morales-Rosello","year":"2005","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1615","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.contraception.2011.09.002","article-title":"Management of the malpositioned levonorgestrel-releasing intrauterine system","volume":"85","author":"Ber","year":"2012","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.004_bib1620","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.contraception.2010.04.152","article-title":"Operative management of intrauterine device complications: a case series report","volume":"82","author":"Turok","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.004_bib1625","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.AOG.0000223201.42144.80","article-title":"Efficacy of intrauterine lidocaine for removal of a \u201clost\u201d intrauterine device: a randomized, controlled trial","volume":"108","author":"Guney","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib1630","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.07.035","article-title":"Loop electrosurgical excision procedure with an intrauterine device in place","volume":"203","author":"Bailey","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.004_bib1635","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/jfprhc-2011-100132","article-title":"Experience with Instillagel(R) for hysterosonography and analgesia in a complex contraception clinic: a QIPP initiative","volume":"38","author":"Pillai","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.004_bib1640","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.contraception.2012.08.009","article-title":"Laboratory screening prior to initiating contraception: a systematic review","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.004_bib1645","author":"Faculty of Sexual and Reproductive Healthcare, Quick Starting Contraception, FSRH Clinical Guidance","year":"2017","journal-title":"Quick start contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.004_bib0825","article-title":"Committee opinion No.\u00a0672: clinical challenges of long-acting reversible contraceptive methods","volume":"128","author":"The American College of Obstetricians Gynecologists\u2019 Committee on Gynecologic Practice, Long-Acting Reversible Contraceptive Expert Work Group","year":"2016","journal-title":"Obstet Gynecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:25:13Z","timestamp":1551209113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918302599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":165,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468718918302599"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.004","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception intra-ut\u00e9rine. RPC Contraception CNGOF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}